Fresenius Medical files suit over U.S. rule change on renal disease care

BERLIN (Reuters) - German kidney dialysis provider Fresenius Medical Care (FMC) said it is challenging a U.S. move to end assistance to patients with end-stage renal disease (ESRD) that it said could have a "material adverse affect" on its business.